126 related articles for article (PubMed ID: 19127806)
1. [Evaluation of visual function among patients with exudative AMD treated with an intravitreal injection of triamcinolone acetonide].
Lubiński W; Gosławski W; Mozolewska-Piotrowska K; Szych Z; Karczewicz D
Ann Acad Med Stetin; 2008; 54(1):22-7; discussion 27. PubMed ID: 19127806
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of retinal function after photodynamic therapy of subfoveal choroidal neovascularisation in patients with age-related macular degeneration].
Mozolewska-Piotrowska K; Lubiński W; Gosławski W; Karczewicz D; Szych Z
Ann Acad Med Stetin; 2007; 53 Suppl 1():16-21; discussion 21. PubMed ID: 19425475
[TBL] [Abstract][Full Text] [Related]
3. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
4. Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP).
Sutter FK; Kurz-Levin MM; Fleischhauer J; Bösch MM; Barthelmes D; Helbig H
Klin Monbl Augenheilkd; 2006 May; 223(5):376-8. PubMed ID: 16705508
[TBL] [Abstract][Full Text] [Related]
5. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Harder B
Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration.
Sutter FK; Kurz-Levin MM; Scherrer M; Barthelmes D; Fleischhauer JC; Helbig H
Klin Monbl Augenheilkd; 2007 Apr; 224(4):297-9. PubMed ID: 17458796
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.
Danis RP; Ciulla TA; Pratt LM; Anliker W
Retina; 2000; 20(3):244-50. PubMed ID: 10872928
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
Roth DB; Kulkarni KM; Walsman S; Modi A
Ophthalmic Surg Lasers Imaging; 2009; 40(5):467-71. PubMed ID: 19772270
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
10. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
11. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
Jonas JB; Degenring RF; Kreissig I; Friedemann T; Akkoyun I
Eye (Lond); 2005 Feb; 19(2):163-70. PubMed ID: 15218517
[TBL] [Abstract][Full Text] [Related]
12. [Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in patients with wet form of AMD. Introductory report].
Mozolewska-Piotrowska K; Krzystolik K; Karczewicz D; Drobek-Słowik M; Kubasik-Kładna K
Klin Oczna; 2011; 113(7-9):233-6. PubMed ID: 22256564
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
[TBL] [Abstract][Full Text] [Related]
14. [ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
Gamulescu MA; Schubert K; Thormann S; Attaran M; Dueck N; Wiechens B; Spital G; Stroux A; Wachtlin J
Klin Monbl Augenheilkd; 2009 Jan; 226(1):60-5. PubMed ID: 19173165
[TBL] [Abstract][Full Text] [Related]
15. [Serum antiretinal antibodies (ARA) in patients with exudative age-related macular degeneration (AMD) treated with transpupillary thermotherapy (TTT) alone and with transpupillary thermotherapy (TTT) combined with injection of triamcinolone acetonide (sTTA) under posterior Tenon's capsule].
Kubicka-Trzaska A; Wilańska J
Klin Oczna; 2011; 113(1-3):28-33. PubMed ID: 21853947
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.
Jonas JB; Kreissig I; Degenring RF
Br J Ophthalmol; 2004 Dec; 88(12):1557-62. PubMed ID: 15548812
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of foveal function in eyes of patients with exudative age-related macular degeneration before and after argon laser treatment].
Lubiński W; Penkala K; Barnyk K; Sych Z; Sylwestrzak Z; Palacz O
Klin Oczna; 2000; 102(3):177-81. PubMed ID: 11126172
[TBL] [Abstract][Full Text] [Related]
18. Trans-Tenon's retrobulbar triamcinolone infusion for myopic choroidal neovascularization.
Kojima A; Ohno-Matsui K; Futagami S; Shimada N; Tokoro T; Mochizuki M
Acta Ophthalmol Scand; 2006 Dec; 84(6):749-54. PubMed ID: 17083532
[TBL] [Abstract][Full Text] [Related]
19. Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B
Ophthalmic Res; 2006; 38(6):324-8. PubMed ID: 17047404
[TBL] [Abstract][Full Text] [Related]
20. [Transpupillary thermotherapy in exudative age-related macular degeneration].
Kubicka-Trzaska A; Starzycka M; Ortyl E; Górniak-Bednarz A; Karska-Basta I
Klin Oczna; 2007; 109(4-6):142-5. PubMed ID: 17725272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
